(3R)-3-((3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-18-AMINO-6-((1S,2S)-2-(3,4-DIHYDROXYPHENYL)-1,2-DIHYDROXYETHYL)-11,20,21,25-TETRAHYDROXY-15-((1R)-1-HYDROXYETHYL)-26-METHYL-2,5,8,14,17,23-HEXAOXO-1,4,7,13,16,22-HEXAZATRICYCLO(22.3.0.09,13)HEPTACOSAN-3-YL)-3-HYDROXYPROPANAMIDE
UNII 486CJC4S7S
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r)-3-((3s,6s,9s,11r,15s,18s,20r,21r,24s,25s,26s)-18-amino-6-((1s,2s)-2-(3,4-dihydroxyphenyl)-1,2-dihydroxyethyl)-11,20,21,25-tetrahydroxy-15-((1r)-1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo(22.3.0.09,13)heptacosan-3-yl)-3-hydroxypropanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 486CJC4S7S.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C35H52N8O17 XQEMNEABNQCDNG-SPSZOZLFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r)-3-((3s,6s,9s,11r,15s,18s,20r,21r,24s,25s,26s)-18-amino-6-((1s,2s)-2-(3,4-dihydroxyphenyl)-1,2-dihydroxyethyl)-11,20,21,25-tetrahydroxy-15-((1r)-1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo(22.3.0.09,13)heptacosan-3-yl)-3-hydroxypropanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.